{"disease":{"id":"hepatic-malignancies","name":"hepatic malignancies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06287411","title":"Role of FAPI PET/MR Combined With Gadoxetate Disodium in Assessing Hepatic Malignancies","phase":"","overall_status":"UNKNOWN","enrollment_count":36,"lead_sponsor_name":"Xiao Chen","has_results":false},{"nct_id":"NCT04332419","title":"Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies","phase":"NA","overall_status":"COMPLETED","enrollment_count":11,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}